29.9% (95% CI: 21.4–39.6%) of KS patients failed to achieve a 100 cell increase in CD4 count compared to 23.3% (95% CI: 22.3–24.3%) of patients without KS. This evidence concerns the gene CD4 and Kaposi's sarcoma.